Vivos Therapeutics, Inc. (VVOS)
0.2765
-0.02
(-6.90%)
USD |
NASDAQ |
Aug 24, 16:00
0.2735
0.00 (0.00%)
After-Hours: 20:00
Vivos Therapeutics Shareholders Equity (Quarterly) : -3.815M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -3.815M |
| March 31, 2026 | -1.138M |
| December 31, 2025 | -1.49M |
| September 30, 2025 | 2.532M |
| June 30, 2025 | 4.583M |
| March 31, 2025 | 4.407M |
| December 31, 2024 | 7.954M |
| September 30, 2024 | 7.665M |
| June 30, 2024 | 6.347M |
| March 31, 2024 | 0.582M |
| December 31, 2023 | 0.411M |
| September 30, 2023 | 0.046M |
| June 30, 2023 | 2.106M |
| March 31, 2023 | 6.993M |
| Date | Value |
|---|---|
| December 31, 2022 | 4.801M |
| September 30, 2022 | 9.855M |
| June 30, 2022 | 14.84M |
| March 31, 2022 | 21.04M |
| December 31, 2021 | 25.54M |
| September 30, 2021 | 32.47M |
| June 30, 2021 | 36.48M |
| March 31, 2021 | 14.34M |
| December 31, 2020 | 16.92M |
| September 30, 2020 | -0.0097M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | -1.626M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Hinge Health, Inc. | 344.33M |
| Exlites Holdings International, Inc. | 0.3419M |
| Xcelerate, Inc. | -2.102M |
| Haemonetics Corp. | 837.10M |
| Pro-Dex, Inc. | 45.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.14M |
| Total Liabilities (Quarterly) | 28.13M |
| Debt to Equity Ratio | -3.278 |
| Current Ratio | 0.2066 |
| Net Debt Paydown Yield | -33.63% |